Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three Month Treatment of GHRH in the Elderly
NCT01410799Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- May 2011
- Primary completion
- Jun 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of growth hormone releasing hormone 1-44 in growth hormone deficiency (GHD), Sarcopenia, sponsored by University of Pennsylvania. Started May 2011; status: terminated.
02
Drugs
growth hormone releasing hormone 1-44
03
Conditions
growth hormone deficiency (GHD)Sarcopenia
Beyond the preview
Go deeper on NCT01410799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410799.